3-amino-2,2-dimethylpropanamide,
3-amino-2,2-dimethylpropanamide,
324763-51-1,
3-AMINO-2,2-DIMETHYLPROPIONAMIDE,
3-amino-2,2-dimethyl-propanamide,
3-Amino-2,2-dimethyl-propionamide,
Propanamide, 3-amino-2,2-dimethyl-,
PubChem23758,
AC1Q1NL0,
SCHEMBL188468,
2-(methylsulfonyl)ethylamineHCl,
CTK3J6183,
2,2-Dimethyl-3-aminopropanamide,
DTXSID30457149,
HKQZJXVIXAPOPZ-UHFFFAOYSA-N,
3-Amino-2,2-dimethylpropionamide,,
BCP04929,
KS-000008UJ,
3-amino-2,2-di(methyl)propionamide,
ANW-51538,
MFCD06797568,
SBB069781,
ZINC22013350,
AKOS009580115,
AC-8492,
AN-6894,
CS-W003343,
GS-4402,
LS40458,
MCULE-6885361465,
PB29404,
RP19249,
RP19251,
RTC-062683,
TRA0061515,
3-Amino-2,2-dimethylpropionic acid amide,
AJ-80547,
AK-34692,
AT-21869,
BC681070,
BR-34692,
SC-23041,
SY021307,
2-(AMINOMETHYL)-2-METHYLPROPANAMIDE,
AB0006150,
ST2417438,
TC-062683,
4CH-003608,
A5817,
AM20090472,
FT-0647546,
X0209,
EN300-42683,
S-4535,
AB00999687-01,
MFCD06797568 (95+%),
763A511,
I05-0176,
Q-102799,
Z444349700,
Intermediate of Aliskiren,
C5H12N2O,
3-Amino-2,2-dimethyl-propylamide,
ACN-048603,
CID11159315,
2-(methylsulfonyl)ethanamine hydrochloride,
2-(TRIFLUOROMETHYL)-4-BROMOPYRIDINE,
A1913,
104458-24-4,
887583-90-6,